Researchers discover mechanism leading to BRAF inhibitor resistance in melanoma patients

19 junio 2015

The development of targeted therapies has significantly improved the survival of melanoma patients over the last decade; however, patients often relapse because many therapies do not kill all of the tumor cells, and the remaining cells adapt to treatment and become resistant. Researchers have discovered a novel mechanism that can lead melanoma cells to develop resistance to drugs that target the protein BRAF.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/7JQnSH3chBA/150619163404.htm

Volver